J&J to enter Chinese CAR-T for myeloma into Phase Ib/II trial
The clinical trial of the CAR-T - a potential competitor to bluebird bio's - will start enrolling patients later this year.
The clinical trial of the CAR-T - a potential competitor to bluebird bio's - will start enrolling patients later this year.